Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours
Authors
Keywords
-
Journal
NATURE CELL BIOLOGY
Volume 20, Issue 7, Pages 775-781
Publisher
Springer Nature
Online
2018-06-22
DOI
10.1038/s41556-018-0118-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Aspartate is an endogenous metabolic limitation for tumour growth
- (2018) Lucas B. Sullivan et al. NATURE CELL BIOLOGY
- Structure and allosteric inhibition of excitatory amino acid transporter 1
- (2017) Juan C. Canul-Tec et al. NATURE
- The Emerging Hallmarks of Cancer Metabolism
- (2016) Natalya N. Pavlova et al. Cell Metabolism
- Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors
- (2016) Shawn M Davidson et al. NATURE MEDICINE
- Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein
- (2015) J. J. Kamphorst et al. CANCER RESEARCH
- An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis
- (2015) Kıvanç Birsoy et al. CELL
- Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells
- (2015) Lucas B. Sullivan et al. CELL
- A roadmap for interpreting 13 C metabolite labeling patterns from cells
- (2015) Joerg M Buescher et al. CURRENT OPINION IN BIOTECHNOLOGY
- Targeting mitochondria metabolism for cancer therapy
- (2015) Samuel E Weinberg et al. Nature Chemical Biology
- Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
- (2014) Kıvanç Birsoy et al. NATURE
- Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment
- (2014) Daniel Ackerman et al. TRENDS IN CELL BIOLOGY
- Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
- (2014) Anne-Theres Henze et al. Nature Communications
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Allosteric Modulation of an Excitatory Amino Acid Transporter: The Subtype-Selective Inhibitor UCPH-101 Exerts Sustained Inhibition of EAAT1 through an Intramonomeric Site in the Trimerization Domain
- (2013) B. Abrahamsen et al. JOURNAL OF NEUROSCIENCE
- The SLC1 high-affinity glutamate and neutral amino acid transporter family
- (2013) Yoshikatsu Kanai et al. MOLECULAR ASPECTS OF MEDICINE
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
- (2013) Cosimo Commisso et al. NATURE
- Mass spectrometry images acylcarnitines, phosphatidylcholines, and sphingomyelin in MDA-MB-231 breast tumor models
- (2012) Kamila Chughtai et al. JOURNAL OF LIPID RESEARCH
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- Metabolic Profiling of Hypoxic Cells Revealed a Catabolic Signature Required for Cell Survival
- (2011) Christian Frezza et al. PLoS One
- Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
- (2010) F. Weinberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the hypoxia-inducible factor (HIF) pathway in cancer
- (2009) Evon Poon et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search